Novel Challenges and Advances in Liver Disease
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy in Clinical Medicine".
Deadline for manuscript submissions: closed (25 March 2025) | Viewed by 308
Special Issue Editor
Special Issue Information
Dear Colleagues,
Liver disease is a general term that refers to any condition affecting the liver. It may develop for different reasons, such as acute or chronic hepatitis by viral, toxic, autoimmune and other causes, fatty liver disease, hepatocellular carcinoma, liver cirrhosis and liver failure. There have been many studies on novel challenges and advances of liver disease, but the field still needs continuous effort and research.
The aim of this Special Issue of JPM is to evaluate and discuss novel challenges and advances in liver disease. It includes the study of disease mechanism, diagnosis and differential diagnosis, medical management, surgical management and prognosis.
We invite colleagues around the world to share their experience and knowledge on novel challenges and advances in liver disease with original studies, reviews or communications in order to develop this important field.
Dr. Suk-Won Suh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liver disease
- hepatitis
- hepatocellular carcinoma
- fatty liver disease
- liver cirrhosis
- liver failure
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
